Ratti L - Search Results

1

Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations.

Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Meloni F, Invernizzi F, Valsecchi MG, Fazio F. Ippolito D, et al. Among authors: ratti l. J Comput Assist Tomogr. 2008 Nov-Dec;32(6):855-8. doi: 10.1097/RCT.0b013e318161dc58. J Comput Assist Tomogr. 2008. PMID: 19204443

2

Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.

Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C, Leone EB, Meloni F, Valsecchi MG, Fazio F. Ippolito D, et al. Among authors: ratti l. Acad Radiol. 2008 Jul;15(7):919-27. doi: 10.1016/j.acra.2008.02.005. Acad Radiol. 2008. PMID: 18572129

3

Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.

Ippolito D, Sironi S, Pozzi M, Antolini L, Invernizzi F, Ratti L, Leone EB, Fazio F. Ippolito D, et al. Among authors: ratti l. Eur J Radiol. 2010 Jan;73(1):148-52. doi: 10.1016/j.ejrad.2008.10.014. Epub 2008 Dec 2. Eur J Radiol. 2010. PMID: 19054640

4

Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.

Ippolito D, Bonaffini PA, Ratti L, Antolini L, Corso R, Fazio F, Sironi S. Ippolito D, et al. Among authors: ratti l. World J Gastroenterol. 2010 Dec 21;16(47):5993-6000. doi: 10.3748/wjg.v16.i47.5993. World J Gastroenterol. 2010. PMID: 21157976 Free PMC article.

5

QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium.

Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Pieruzzi F, Vincenti A, Stella A, Mancia G, Stramba-Badiale M. Genovesi S, et al. Among authors: ratti l. Clin Sci (Lond). 2009 May 14;116(12):851-9. doi: 10.1042/CS20080325. Clin Sci (Lond). 2009. PMID: 19076059

6

Potential therapeutic targets in cirrhotic cardiomyopathy.

Pozzi M, Ratti L, Guidi C, Milanese M, Mancia G. Pozzi M, et al. Among authors: ratti l. Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):21-6. doi: 10.2174/187152907780059074. Cardiovasc Hematol Disord Drug Targets. 2007. PMID: 17346125 Review.

7

Portal pressure reduction after entecavir treatment in compensated HBV cirrhosis.

Pozzi M, Pizzala DP, Maldini FF, Doretti A, Ratti L. Pozzi M, et al. Among authors: ratti l. Hepatogastroenterology. 2009 Jan-Feb;56(89):231-5. Hepatogastroenterology. 2009. PMID: 19453064

8

Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient.

Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Vincenti A, Stella A, Mancia G. Genovesi S, et al. Among authors: ratti l. Liver Int. 2010 Feb;30(2):232-9. doi: 10.1111/j.1478-3231.2009.02125.x. Epub 2009 Sep 28. Liver Int. 2010. PMID: 19793198

9

Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients.

Ratti L, Pozzi M, Bosch J. Ratti L, et al. Dig Liver Dis. 2005 Nov;37(11):886-93. doi: 10.1016/j.dld.2005.04.029. Epub 2005 Sep 19. Dig Liver Dis. 2005. PMID: 16172033

10

The pulmonary involvement in portal hypertension: portopulmonary hypertension and hepatopulmonary syndrome.

Ratti L, Pozzi M. Ratti L, et al. Gastroenterol Hepatol. 2006 Jan;29(1):40-50. doi: 10.1016/s0210-5705(06)71595-3. Gastroenterol Hepatol. 2006. PMID: 16393630 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters